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We studied, by electrophoretic echniques, the physicoehemical properties of4 glycoproteins, a,-antitrypsin, 
a,-antichymotrypsin, a,-acid glycoprotein and transferrin synthesized by three different human hepatoma 
cell lines. A common feature was the export of glycoproteins with retarded electrophoretic mobility, indicat- 
ing incomplete sialylation, and a predominance of atypical, highly branched carbohydrate chains. The ab- 
normal glycosylation pattern may be specific for malignant transformation f hepatocytes and possibly re- 
lated to the intracellular ccumulation f some of these proteins in malignant cells. 
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1. INTRODUCTION 
Several human hepatocellular carcinoma cell 
lines have biosynthetic capabilities similar to those 
of normal liver parenchymal cells. The lines Hep 
G2 and Hep 3B synthesize and secrete most major 
plasma proteins including albumin and LY- 
fetoprotein [I]. Another previously described line 
(PLC/PRF/S) [2] has a narrower range of syn- 
thetic ability but expresses HB,Ag a property in 
common with Hep 3B. The availability of these cell 
lines in continuous culture provide a major tool for 
studies of biosynthetic patterns and mechanisms 
modulating the rate of biosynthesis of individual 
proteins. Nearly all plasma proteins are glycopro- 
teins the majority of which are formed by N- 
glycosylation. The intracellular transfer is assumed 
to be receptor mediated with characteristic rates 
for the different proteins [3]. Before export from 
the hepatocyte the high-mannose core oligosac- 
charide is trimmed resulting in the final complex 
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glycoprotein having sialic acid, the only electrically 
charged sugar residue, at the terminal ‘position. 
The mobility on agarose electrophoresis reflects 
the number of sialic acid residues. In the process of 
trimming and complex glycosylation variations in 
the branching of the oligosaccharide occur. Chains 
exist as bi-, tri-, tetraantennary or hybrid forms. 
Circulating glycoproteins exhibit a large degree of 
microheterogeneity which can be studied by 
crossed affinoimmunoelectrophoresis with lectins 
particularly concanavalin A (Con A). Only glycans 
corresponding to the bi-antennary structure, which 
is the least modified in the glycosylation process, 
bind to Con A [4]. 
We have previously used PLC/PRF/S to 
delineate the biosynthetic steps for human 
cyr-antitrypsin (AAT) and found that this process is 
similar to that found for rat AAT [5]. However, it 
was demonstrated that export AAT from these 
hepatocytes, although having a normal molecular 
size, had a retarded electrophoretic mobility con- 
sistent with incomplete terminal sialylation of the 
glycoprotein. In addition Con A electrophoresis 
displayed reduced affinity indicating an excess of 
highly branched but incompletely sialylated car- 
bohydrate chains. We extended these studies to in- 
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elude cur-antichymotrypsin (ACT), another closely 
related antiprotease and acute phase reactant; 
al-acid glycoprotein (AGP), a non-antiprotease 
acute phase reactant with high carbohydrate con- 
tent; and transferrin (TRF), a glycoprotein whose 
export does not increase in acute phase situations. 
2. MATERIALS AND METHODS 
PLC/PRF/S cells were maintained as described 
[5]. The cell lines Hep G2 and 3B were provided by 
Dr Darlington, Department of Pathology, Baylor 
College of Medicine, Houston, TX, with the kind 
permission of Dr B. Knowles, Wistar Institute, 
Philadelphia. They were maintained as described 
[1,5]. To avoid high concentrations of fetal calf 
serum standard medium was replaced by Williams 
medium E supplemented as described [5] in some 
experiments. 
Quantitation of proteins in cell culture media 
was performed by electroimmunoassay [6] using 
dilutions of a standard normal serum (Seronorm@ 
Protein, Nyegaard & Co., Oslo, Norway) as 
reference. Monospecific antisera against AAT, 
TRF, and AGP were gifts from the Department of 
Clinical Chemistry, Malmo, antiserum against 
ACT was purchased from Dakopatts, Copen- 
hagen, Denmark. Crossed immunoelectrophoresis 
was performed according to Ganrot [7] and 
crossed affinoimmunoelectrophoresis with free 
Con A in the first dimension according to Hansen 
et al. [S]. [35S]Methionine labelling of export pro- 
teins as described [5]. SDS-PAGE was carried out 
as previously described with 20 x 30 cm slab gels 
containing a lo- 15 % polyacrylamide gradient 
with a 2 cm spacing gel [5]. Sialidase activity in cell 
cultures was analyzed by adding 0.5 ml normal 
human serum to 5 ml medium with cells close to 
confluence in a culture flask. Incubation was then 
continued for 24 h at 37°C and electrophoretic 
mobility of the glycoproteins in the medium was 
studied by crossed immunoelectrophoresis. 
3. RESULTS AND DISCUSSION 
The approximate concentrations of the different 
proteins reached in culture media at confluence is 
given in table 1. All individual glycoproteins 
studied show a more or less pronounced retarded 
mobility towards the anode. The patterns with 
Table 1 
Electroimmunoassay of 4 glycoproteins in hepatoma 
supernatants 
Protein Carbo- Cell line 
hydrate 
content PLC/PRF/S Hep G2 Hep 3B 
(%) 
AAT 12 0.95 0.65 0.15 
ACT 25 Oa 0.45 Oa 
AGP 45 <O.Ol 0.05 0.02 
TRF 6 0.04 0.50 0.18 
Concentrations are expressed as per cent of normal 
plasma level (= 100). a Not detectable 
broad, heterogenous and retarded peaks of ACT, 
TRF and AGP on crossed immunoelectrophoresis 
(fig. 1) is uniform and resembles that described for 
AAT [5]. After [35S]methionine labelling export 
ACT was studied and appeared as a broad, 
heterogenous immunoprecipitate. Tunicamycin, 
known to totally prevent addition of asparagine- 
linked carbohydrate chains, resulted in delayed ex- 
port of a smaller molecule with sharper demarca- 
tion of the immunoprecipitate (fig.2). The experi- 
ment demonstrates that ACT heterogeneity resides 
in the carbohydrate chains rather than in the 
polypeptide. Absence of sialidase activity in the 
media (not shown) suggests incomplete de novo 
sialylation rather than postexport alterations. On 
crossed affinoimmunoelectrophoresis a low lectin 
A ,,/, 
Fig. 1. Crossed immunoelectrophoresis of a normal 
plasma pool (above) and medium from Hep G2 (below). 
ACT (A), AGP (B) and TRF (C). The electrophoretic 
pattern of normal plasma is given for reference. Anode 
to the left. Medium was collected after 3 days culture 
and concentrated 20 x before analysis. 
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Fig.2. SDS-PAGE of immunoprecipitated export ACT 
from a pulse chase experiment. Hep G2 cells were 
incubated for 75 min in a methionine deficient medium 
with tunicamycin 3 pg/ml in lanes marked T. Pulse time 
was 15 min with 100,&i [?3]methionine per culture. 
SDS-PAGE in a lo-15% gradient slab gel with 
fluorographic enhancement is shown at chase time 60,90 
and 120 min. 
affinity was noted. The patterns are similar to that 
previously described for AAT (fig.3) and indicate, 
in addition to hyposialylation, a relative 
predominance of highly branched carbohydrate 
chains. 
The data presented thus indicate the presence of 
a similar glycosylation defect in 4 different 
glycoproteins secreted from 3 different cell lines 
and therefore suggest a common underlying 
mechanism. At present it is uncertain whether 
these alterations are due to cell culture conditions 
or to inherent characteristics of the malignant cells 
per se. If the putative mechanism is operating in 
vivo one would anticipate the biosynthesis and ex- 
port of incompletely sialylated glycoproteins from 
hepatoma cells with a very rapid clearance from 
the circulation due to binding by the hepatic 
c 
Fig.3. Crossed Con A affinoimmunoelectrophoresis of 
ACT (I) and AGP (II). A, normal plasma pool; B, Hep 
G2 medium concentrated 20 x and C, mixture of equal 
volumes of A and B. Anode to the left. Second 
dimension: 0.7% anti-human ACT and 1 Qo anti-human 
AGP, 4% PEG 6000 respectively and 50 mM methyl-cu- 
D-mannopyranoside. 
galactose-binding protein [9]. The presence of 
small amounts of asialoglycoproteins in the cir- 
culation has been demonstrated by indirect tech- 
niques in a variety of liver diseases [lo] and do not 
seem to be a specific feature of malignantly 
transformed hepatocytes although one remarkable 
case has been reported [ 111. The presence of an ex- 
cess of triantennary carbohydrate chains has been 
described for AAT in acute phase situations [ 121. 
Presently, however, one may speculate that the 
carbohydrate chains of the proteins studied here 
are not only highly branched but in addition 
atypical and similar to the unusual biantennary, 
complex and asialylated sugar chains that have 
been shown to be present in choriongonadotropin 
produced by a chorioncarcinoma [131. The Con A 
affinoimmunoelectrophoresis a relatively crude 
technique, incapable of providing subtle structural 
details. When interpreting results it is also impor- 
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tant to carefully consider the proportions between 
total amount of glycoprotein applied to the gels 
and their Con A content [8]. We therefore studied 
the influence of increasing Con A concentrations 
(l-lo.5 mg/ml) on the pattern shown in fig.3. 
Higher concentrations resulted in slower mobility 
and slightly improved resolution but did not 
change the basic pattern (not shown). 3 mg/ml was 
found to be the optimal concentration to 
demonstrate differences between normal and 
hepatoma proteins in this system. 
Intracellular AAT revealed by periodic-acid 
Schiff staining or by immunoperoxidase tech- 
niques in PLC/PRF/S cells may be an expression 
of an inability of hepatoma cells to glycosylate ex- 
port proteins completely thus promoting in- 
tracellular accumulation [5]. There is increasing 
evidence that AAT accumulation may occur not 
only in hepatoma tissue but also in many other 
tumours [14] suggesting a broader significance of 
AAT as a tumour marker. Recently ACT has also 
been shown, by the immunoperoxidase technique, 
to accumulate in hepatoma cells and to be even 
more sensitive than AAT as a tumour marker [ 151. 
The appearance of abnormally glycosylated export 
proteins in the circulation and/or in malignant 
hepatocytes may thus have a potential diagnostic 
value. 
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